Cancer and diabetes: Two pathological conditions in which adrenomedullin may be involved

Peptides

Volumn 22, Issue 11, 2001, Pages 1719-1729

  Pío, Rubén ^a   Martínez, Alfredo ^b   Cuttitta, Frank ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adrenomedullin; Binding protein; Cancer; Diabetes; Embryogenesis; Factor H; Growth; Insulin secretion

Indexed keywords

ADRENOMEDULLIN; BINDING PROTEIN; COMPLEMENT FACTOR H; INSULIN;

ARTICLE; CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DIABETES MELLITUS; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; INSULIN RELEASE; MITOGENESIS; PANCREAS FUNCTION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADRENOMEDULLIN; ANIMALS; CELL DIVISION; COMPLEMENT FACTOR H; DIABETES MELLITUS; HUMANS; NEOPLASMS; PANCREAS; PEPTIDES;

EID: 0035685133     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(01)00530-7     Document Type: Article

References (112)

1. Proadrenomedullin N-terminal 20 peptide (PAMP) inhibits proliferation of human neuroblastoma TGW cells
2. Adrenomedullin enhances cell proliferation and deoxyribonucleic acid synthesis in rat adrenal zona glomerulosa: Receptor subtype involved and signaling mechanism
3. Oncogenes and the strategy of growth factors
4. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
5. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene
6. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway
7. A very sensitive coupled luminescent assay for cytotoxicity, and complement-mediated lysis
8. Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo
9. The role of adrenomedullin as a growth regulatory peptide in the normal and malignant setting
10. Complement evasion by Echinococcus granulosus: Sequestration of host factor H in the hydatid cyst wall
11. Interaction of adrenomedullin with calcitonin receptor in cultured human breast cancer cells, T 47D
12. Human polymorphonuclear leukocytes adhere to complement factor H through an interaction that involves alphaMbeta2 (CD11b/CD18)
13. Gene expression of neuronal nitric oxide synthase and adrenomedullin in human neuroblastoma using real-time PCR
14. High levels of circulating adrenomedullin in severe illness: Correlation with C-reactive protein and evidence against the adrenal medulla as site of origin
15. Adrenomedullin binding protein in the plasma of multiple species: Characterization by radioligand blotting
16. Underlying disease stress augments plasma and tissue adrenomedullin (AM) responses to endotoxin: Colocalized increases in AM and inducible nitric oxide synthase within pancreatic islets
17. Factor H binding to bone sialoprotein, and osteopontin enables tumor cell evasion of complement-mediated attack
18. Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA)
19. Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: A possible promotion mechanism of carcinogenesis
20. Plasma adrenomedullin levels in type 1 diabetes. Relationship with clinical parameters
21. Expression of complement components of the alternative pathway by glioma cell lines
22. Human skeletal myoblasts spontaneously activate allogeneic complement but are resistant to killing
23. Complement activation on human neuroblastoma cell lines in vitro: Route of activation and expression of functional complement regulatory proteins
24. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density
25. The hallmarks of cancer
26. The physiological breakdown of the third component of human complement
27. Changes in vasoactive substances during gastric ulcer healing
28. Expression of the adrenomedullin gene in epithelial ovarian cancer
29. Hyperglycemia increases vascular adrenomedullin expression
30. Plasma adrenomedullin in diabetes
31. Adrenomedullin, a multifunctional regulatory peptide
32. Tissue hypoxygenation activates the adrenomedullin system in vivo
33. Antiphagocytic activity of streptococcal M protein: Selective binding of complement control protein factor H
34. Analysis of serum insulin-like growth factor binding proteins using western blotting: Use of the method for titration of the binding proteins and competitive binding studies
35. Evidence for an active hydrophobic form of factor H that is able to induce secretion of interleukin 1-β or by human monocytes
36. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure
37. Adrenomedullin production in fibroblasts: Its possible function as a growth regulator of Swiss 3T3 cells
38. Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: Role of tyrosine kinase-mediated mitogen-activated protein kinase activation
39. Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1
40. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells
41. Adrenomedullin has mitogenic effects on human oral keratinocytes: Involvement of cyclic AMP
42. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells
43. Receptors for adrenomedullin in human vascular endothelial cells
44. Synthesis and regulation of complement protein factor H in human skin fibroblasts
45. Complement factor H or a related protein is a marker for transitional cell cancer of the bladder
46. Plasma adrenomedullin levels in patients with diabetes
47. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
48. Induction of adrenomedullin during hypoxia in cultured human glioblastoma cells
49. Adrenomedullin production is correlated with differentiation in human leukemia cell lines and peripheral blood monocytes
50. Expression of the complement alternative pathway by human myoblasts in vitro: Biosynthesis of C3, factor B, factor H and factor I
51. Adrenomedullin gene expression and its different regulation in human adrenocortical and medullary tumors
52. Adrenomedullin in nonmammalian vertebrate pancreas: An immunocytochemical study
53. Identification of human complement Factor H as a ligand for L-selectin
54. The application of human complement factor H-related protein (BTA TRAK) in monitoring patients with bladder cancer
55. Immunohistochemical localization of adrenomedullin in fetal and neonatal lung
56. Growth factors and cutaneous wound repair
57. Expression pattern for adrenomedullin during pancreatic development in the rat reveals a common precursor with other endocrine cell types
58. Is adrenomedullin a causal agent in some cases of type 2 diabetes?
59. Expression of adrenomedullin and its receptor in normal and malignant human skin: A potential pluripotent role in the integument
60. Coexpression of receptors for adrenomedullin, calcitonin gene-related peptide, and amylin in pancreatic β-cells
61. Expression of adrenomedullin in normal human lung and in pulmonary tumors
62. Regulation of insulin secretion and blood glucose metabolism by adrenomedullin
63. Adrenomedullin involvement in wound repair
64. Autocrine/paracrine role of adrenomedullin in cultured endothelial, and mesangial cells
65. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor
66. Coordinate expression of transforming growth factor-β1 and adrenomedullin in rodent embryogenesis
67. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action
68. Proadrenomedullin NH(2)-terminal 20 peptide (PAMP), and adrenomedullin bind to teratocarcinoma cells
69. Adrenomedullin binds with high affinity, elevates cyclic AMP, and stimulates c-fos mRNA in C6 glioma cells
70. Adrenomedullin: Localization in the gastrointestinal tract, and effects on insulin secretion
71. Expression of adrenomedullin and adrenomedullin mRNA in ectopic ACTH-secreting tumors
72. Identification of human complement factor H as a chemotactic protein for monocytes
73. Does acute hyperinsulinaemia change plasma adrenomedullin concentration in healthy men?
74. Plasma adrenomedullin levels in patients with non-insulin dependent diabetes mellitus: Close relationships with diabetic complications
75. Production and secretion of two vasoactive peptides, endothelin-1 and adrenomedullin, by a colorectal adenocarcinoma cell line, DLD-1
76. Transcriptional control of adrenomedullin induction by phorbol ester in human monocytic leukemia cells
77. Induction of adrenomedullin by hypoxia and cobalt chloride in human colorectal carcinoma cells
78. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H
79. Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium
80. Regulation of glomerular mesangial cell proliferation in culture by adrenomedullin
81. Complement factor H is a serum binding protein for adrenomedullin. The resulting complex modulates the bioactivities of both partners
82. Binding of complement factor H to loop 5 of porin protein 1A: A molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae
83. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae
84. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma
85. Immunoreactive adrenomedullin in human adrenal glands and adrenal tumors
86. Human complement factor H: Expression of an additional truncated gene product of 43 kDa in human liver
87. Inhibitory effect of adrenomedullin on rat mesangial cell mitogenesis
88. Pattern of degradation of human complement fragment, C3b
89. Endothelial cells actively synthesize and secrete adrenomedullin
90. Production and secretion of adrenomedullin by cultured choroid plexus carcinoma cells
91. Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production
92. Expression of adrenomedullin mRNA in adrenocortical tumors and secretion of adrenomedullin by cultured adrenocortical carcinoma cells
93. Production and secretion of two vasoactive peptides, adrenomedullin and endothelin-1, by cultured human adrenocortical carcinoma cells
94. Reduced adrenomedullin expression in gastric mucosa of portal hypertensive rats after ethanol-induced injury
95. Inhibition of stimulated amylase secretion by adrenomedullin in rat pancreatic acini
96. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth
97. Adrenomedullin in cultured human retinal pigment epithelial cells
98. Increased expression of adrenomedullin mRNA in the tissues of intraocular and orbital tumors
99. Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulations
100. Sequential expression of adrenomedullin and its receptor during gastric ulcer healing in rats
101. Ethanol injury triggers activation of adrenomedullin and its receptor genes in gastric mucosa
102. The Adrenomedullin gene is a target for negative regulation by the Myc transcription complex
103. Oxygen(es), and the hypoxia-inducible factor-1
104. Modulation of the alternative complement pathways by beta 1 H globulin
105. Characterization of the 5′ flanking region of the human complement factor H gene
106. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells
107. Review of diabetes: Identification of markers for early detection, glycemic control, and monitoring clinical complications
108. Expression of adrenomedullin, a hypotensive peptide, in the trophoblast giant cells at the embryo implantation site in mouse
109. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium
110. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases
111. Adrenomedullin and calcitonin gene-related peptide interact with the same receptor in cultured human neuroblastoma SK-N-MC cells